Immunohistochemical analysis of IQGAP2 in ovarian cancer
Journal Title: European Journal of Gynaecological Oncology - Year 2019, Vol 40, Issue 1
Abstract
IQ motif-containing GTPase-activating protein 2 (IQGAP2) was regarded as a tumor suppressor in some cancers, but its expression pattern in various histological subtypes of ovarian cancer has not been investigated. Immunohistochemical staining for IQGAP2 was conducted with two human ovarian tissue microarrays containing 250 ovarian tumors and 39 normal ovarian tissues in total. Positive staining of IQGAP2 was observed in cytoplasm as well as on membrane. IQGAP2 was expressed in 48.7% of normal ovarian tissues, 37.9% of serous cancers, 66.7% of mucinous cancer, 71.4% of endometrioid cancers, 100% of clear cell cancers, 25% of endodermal sinus tumors, and immature teratomas. Contrarily, IQGAP2 was absent in dysgerminomas, transitional, and granulosa cell tumors. The mean IQGAP2 immunohistochemical composite scores were 1.92 for normal ovarian tissues,1.69 for serous cancers, 4.51 for mucinous cancers, 3.00 for endometrioid cancers, 7.71 for clear cell cancers, 0.25 for endodermal sinus tumors, and 1 for immature teratomas. Compared with normal ovarian tissues, the overall positivity of IQGAP2 in clear cell cancers and the mean composite scores of IQGAP2 in clear cell and mucinous cancers were significantly higher, while the mean composite scores of IQGAP2 in dysgerminomas, endodermal sinus tumor, and granulosa cell tumors was significantly lower. The authors concluded that IQGAP2 might serve as a tumor suppressor in dysgerminomas, endodermal sinus tumor, and granulosa cell tumors of ovary. Understanding the role of IQGAP2 in the pathogenesis of ovarian cancers necessitates further study.
Authors and Affiliations
Xiang Wang, Zhuo Deng, Lijie Wang, He Chen, Huilian Hou, Xu Li
Keywords
Related Articles
- EP ID EP663030
- DOI 10.12892/ejgo4408.2019
- Views 71
- Downloads 0
Taraxacum officinale extract induces antitumorigenic effects in ovarian carcinoma cell lines
Purpose of Investigation: Patients suffering from ovarian cancer often use mistletoe preparations in combination with Taraxacum officinale (dandelion) extracts as supplementary therapy to conventional medicine. However,...
Concurrent chemoradiotherapy combined with immunotherapy is superior to traditional concurrent chemoradiotherapy in the treatment of advanced cervical cancer
Purpose of investigation: In advanced cervical cancer, traditional therapy included concurrent chemoradiotherapy (CCRT), pelvic radiotherapy, and brachytherapy. In the last few years, the development of using of immunoth...
Cytoreductive surgery combined with HIPEC in newly diagnosed and recurrent ovarian cancer
Objective: Perioperative intraperitoneal chemotherapy after cytoreductive surgery is used in ovarian cancer treatment. The purpose of the study is the evaluation of the effect of hyperthermic intraoperative intraperitone...
Plasma fibrinogen, CRP, and hs-CRP levels in patients with benign and borderline ovarian tumours
Objective: Ovarian tumours can be classified as benign, borderline or malignant lesions. The purpose of this study was to assess, inter alia, fibrinogen concentration, and the (C-reactive proteins) and high-sensitivity C...
The association of microcystic, elongated, and fragmented (MELF) invasion pattern in endometrial carcinomas with prognostic factors
Purpose: One of the most important prognostic factors for endometrial carcinoma (EC) is myometrial invasion. Microcystic, elongated, and fragmented (MELF) myometrial invasion (MI) pattern is also important in terms of di...